The Orbital Fibroblast: A Key Player and Target for Therapy in Graves' Ophthalmopathy

被引：29
|
作者：
van Steensel, Leendert [1 ]
Dik, Willem A. [1 ]
机构：
[1] Erasmus MC, Dept Immunol, POB 2040, NL-3000 CA Rotterdam, Netherlands
来源：
ORBIT-AN INTERNATIONAL JOURNAL ON ORBITAL DISORDERS AND FACIAL RECONSTRUCTIVE SURGERY | 2010年 / 29卷 / 04期
关键词：
Graves' Ophthalmopathy; Orbital fibroblast; PDGF; Therapy; Pathogenesis;
D O I：
10.3109/01676831003668443
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
Orbital fibroblasts play a key role in the pathogenesis of Graves' ophthalmopathy (GO). We discuss some major aspects by which orbital fibroblasts contribute to GO and the important role of PDGF-BB herein. Finally, we propose the orbital fibroblast, and especially the PDGF system acting on orbital fibroblasts, as an important therapeutic target in GO.
引用
收藏
页码：202 / 206
页数：5
相关论文
共 50 条
  • [1] Graves' ophthalmopathy. Pathogenesis, diagnosis and therapy
    Heufelder, AE
    Hofbauer, LC
    Schworm, HD
    MEDIZINISCHE WELT, 1997, 48 (06): : 230 - 238
  • [2] Bony Orbital Surgery for Graves' Ophthalmopathy
    Ong, Adrian A.
    DeVictor, Samuel
    Vincent, Aurora G.
    Namin, Arya W.
    Wang, Weitao
    Ducic, Yadranko
    FACIAL PLASTIC SURGERY, 2021, 37 (06) : 692 - 697
  • [3] Endoscopic orbital decompression for Graves' ophthalmopathy
    Levy, J
    Puterman, M
    Lifshitz, T
    Marcus, M
    Segal, A
    Monos, T
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2004, 6 (11): : 673 - 676
  • [4] Orbital fat prolapse and Graves' ophthalmopathy
    Teixeira, Kim-Ir-Sen Santos
    Feres, Rachel Campelo
    do Nascimento Garcia Pereira, Gustavo Maurilio
    Reboucas Moreira, Marise Amaral
    de Sousa Camargo Andrade, Dorislay Barbosa
    REVISTA BRASILEIRA DE OFTALMOLOGIA, 2009, 68 (02) : 103 - 106
  • [5] Dihydroartemisinin Exerts Antifibrotic and Anti-Inflammatory Effects in Graves' Ophthalmopathy by Targeting Orbital Fibroblasts
    Yang, Shenglan
    Wang, Xing
    Xiao, Wei
    Xu, Zhihui
    Ye, Huijing
    Sha, Xiaotong
    Yang, Huasheng
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [6] Thalidomide inhibits adipogenesis of orbital fibroblasts in Graves' ophthalmopathy
    Zhang, Chu
    Zhang, Xianfeng
    Ma, Lizhen
    Peng, Fengying
    Huang, Jiao
    Han, Hui
    ENDOCRINE, 2012, 41 (02) : 248 - 255
  • [7] EZH2 as a major histone methyltransferase in PDGF-BB-activated orbital fibroblast in the pathogenesis of Graves' ophthalmopathy
    Visamol, Sopita
    Palaga, Tanapat
    Saonanon, Preamjit
    Pruksakorn, Vannakorn
    Hirankarn, Nattiya
    van Hagen, P. Martin
    Dik, Willem A.
    Virakul, Sita
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [8] Outcomes of endoscopic orbital decompression for graves’ ophthalmopathy
    Robbie S. R. Woods
    Qistina Pilson
    Natallia Kharytaniuk
    Lorraine Cassidy
    Rizwana Khan
    Conrad V. I. Timon
    Irish Journal of Medical Science (1971 -), 2020, 189 : 177 - 183
  • [9] Orbital Lymphoma Mimicking Ophthalmopathy in a Patient With Graves'
    Moura Neto, Arnaldo
    Denardi, Fernanda Canova
    Delamain, Marcia T.
    Tambascia, Marcos Antonio
    Vassallo, Jose
    Caldato, Roberto
    Zantut-Wittmann, Denise Engelbrecht
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2012, 344 (05): : 418 - 421
  • [10] Outcomes of endoscopic orbital decompression for graves' ophthalmopathy
    Woods, Robbie S. R.
    Pilson, Qistina
    Kharytaniuk, Natallia
    Cassidy, Lorraine
    Khan, Rizwana
    Timon, Conrad V., I
    IRISH JOURNAL OF MEDICAL SCIENCE, 2020, 189 (01) : 177 - 183
12345